As of 2024-12-15, the Relative Valuation of Altimmune Inc (ALT) is (32.60) USD. This relative valuation is based on P/E multiples. With the latest stock price at 9.03 USD, the upside of Altimmune Inc based on Relative Valuation is -461.1%.
The range of the Relative Valuation is (30.16) - (27.98) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 20.7x - 31.0x | 25.8x |
| Forward P/E multiples | 18.7x - 19.2x | 19.0x |
| Fair Price | (30.16) - (27.98) | (32.60) |
| Upside | -434.0% - -409.8% | -461.1% |
| Date | P/E |
| 2024-12-12 | -5.90 |
| 2024-12-11 | -6.00 |
| 2024-12-10 | -6.19 |
| 2024-12-09 | -6.62 |
| 2024-12-06 | -6.26 |
| 2024-12-05 | -6.28 |
| 2024-12-04 | -6.77 |
| 2024-12-03 | -6.04 |
| 2024-12-02 | -6.08 |
| 2024-11-29 | -5.89 |
| 2024-11-27 | -6.00 |
| 2024-11-26 | -5.79 |
| 2024-11-25 | -5.89 |
| 2024-11-22 | -5.96 |
| 2024-11-21 | -5.77 |
| 2024-11-20 | -5.53 |
| 2024-11-19 | -5.13 |
| 2024-11-18 | -4.91 |
| 2024-11-15 | -5.23 |
| 2024-11-14 | -5.81 |
| 2024-11-13 | -6.54 |
| 2024-11-12 | -6.52 |
| 2024-11-11 | -5.05 |
| 2024-11-08 | -5.28 |
| 2024-11-07 | -5.13 |
| 2024-11-06 | -5.02 |
| 2024-11-05 | -4.83 |
| 2024-11-04 | -4.66 |
| 2024-11-01 | -4.63 |
| 2024-10-31 | -4.63 |
| 2024-10-30 | -4.64 |
| 2024-10-29 | -5.06 |
| 2024-10-28 | -4.82 |
| 2024-10-25 | -4.60 |
| 2024-10-24 | -4.65 |
| 2024-10-23 | -4.62 |
| 2024-10-22 | -4.67 |
| 2024-10-21 | -4.74 |
| 2024-10-18 | -4.73 |
| 2024-10-17 | -4.66 |
| 2024-10-16 | -4.71 |
| 2024-10-15 | -4.84 |
| 2024-10-14 | -4.42 |
| 2024-10-11 | -4.33 |
| 2024-10-10 | -4.14 |
| 2024-10-09 | -4.20 |
| 2024-10-08 | -4.29 |
| 2024-10-07 | -4.19 |
| 2024-10-04 | -4.28 |
| 2024-10-03 | -4.23 |